iSpecimen Inc. (ISPC) income statement
ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 17, 2026Score 7/3045% below fair value
$0.60−0.01 (-1.45%)
Close on Nov 17, 2026Market cap $1.50MP/E –Yield –
iSpecimen Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- -98.0%
- Operating margin
- -2020.0%
- Net margin
- -2449.0%
- Return on equity, FY2025
- -327.8%
Financial strength
- Current ratio
- 0.82
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 80.6%
Valuation
- P/E ratio
- –
- Price to sales
- 3.22
- Price to book
- 0.86
- Dividend yield
- –
See a number that looks wrong?